These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Adenocarcinoma of the uterine cervix: a study of 37 cases. Piura B, Dgani R, Yanai-Inbar I, Cohen Y, Glezerman M. J Surg Oncol; 1996 Apr; 61(4):249-55. PubMed ID: 8627993 [Abstract] [Full Text] [Related]
7. Prognostic factors affecting the outcome of early cervical cancer treated with radical hysterectomy and post-operative adjuvant therapy. Liu MT, Hsu JC, Liu WS, Wang AY, Huang WT, Chang TH, Pi CP, Huang CY, Huang CC, Chou PH, Chen TH. Eur J Cancer Care (Engl); 2008 Mar; 17(2):174-81. PubMed ID: 18302655 [Abstract] [Full Text] [Related]
8. Radical pelvic surgery versus radical surgery plus radiotherapy for stage Ib carcinoma of the cervix uteri. Preliminary results of a prospective randomized clinical study. Bilek K, Ebeling K, Leitsmann H, Seidel G. Arch Geschwulstforsch; 1982 May; 52(3):223-9. PubMed ID: 6751268 [Abstract] [Full Text] [Related]
9. Concurrent chemoradiotherapy with nedaplatin after radical hysterectomy in patients with stage IB and II cervical cancer. Kobayashi Y, Ohara T, Wada Y, Okuda Y, Kondo H, Okuma Y, Suzuki N, Gomi H, Kiguchi K, Ishizuka B. J Obstet Gynaecol Res; 2009 Jun; 35(3):490-4. PubMed ID: 19527388 [Abstract] [Full Text] [Related]
15. Prognosis and clinicopathological characteristics of Ib-IIb adenocarcinoma of the uterine cervix in patients who have had radical hysterectomy. Irie T, Kigawa J, Minagawa Y, Itamochi H, Sato S, Akeshima R, Terakawa N. Eur J Surg Oncol; 2000 Aug; 26(5):464-7. PubMed ID: 11016467 [Abstract] [Full Text] [Related]